Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,947 public trials 2,015 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin Lymphoma

NCT05201248

Conditions
B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • The Fifth Medical Center of PLA General Hospital /ID# 230520 Beijing, Beijing Municipality, China
  • Peking University Third Hospital /ID# 228138 Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital /ID# 231890 Fuzhou, Fujian, China
  • Sun Yat-Sen University Cancer Center /ID# 228033 Guangzhou, Guangdong, China
View all 18 locations
View Trial Details
Active, Not Recruiting

Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL

NCT03836261

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Redondo Beach, California, United States
  • Research Site Fort Wayne, Indiana, United States
  • Research Site Wichita, Kansas, United States
View all 170 locations
View Trial Details
Active, Not Recruiting

Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial

NCT03150914

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Stanford University Palo Alto, California, United States
  • National Jewish Hospital Denver, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Loyola University Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN

NCT03386513

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Disease Attributes, +25 more
Locations
  • Banner Health MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • UCLA Los Angeles, California, United States
  • Stanford Stanford, California, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS)

NCT03385226

Conditions
Cutaneous T Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +16 more
Locations
  • University Hospital Birmingham Birmingham, United Kingdom
  • Velindre Cancer Centre Cardiff, United Kingdom
  • University Hospital Coventry Coventry, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
View Trial Details

Related conditions